Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18602677 | COMPOSITION FOR SKIN WHITENING COMPRISING CARVEDILOL | March 2024 | June 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18045745 | DRY FORMULATIONS OF ANTI-SARS-COV-2 VIRUS ANTIBODIES AND COMPOSITIONS AND METHODS OF USE THEREOF | October 2022 | June 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17934626 | PAIN RELIEF SALVE AND A METHOD FOR MAKING SUCH | September 2022 | May 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17513384 | COMPOSITION AND METHOD FOR STIMULATING PLANT GROWTH AND PRODUCTIVITY | October 2021 | April 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17363593 | Antimicrobial Compositions and Uses Thereof | June 2021 | July 2022 | Abandon | 13 | 1 | 1 | No | No |
| 17323109 | PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS ACTIVE METABOLITES FOR DRY POWDER INHALATION | May 2021 | November 2022 | Abandon | 18 | 1 | 1 | No | No |
| 16944800 | Flumioxazin Compositions | July 2020 | November 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16765148 | NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE | May 2020 | July 2022 | Abandon | 26 | 1 | 0 | No | No |
| 16865882 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING AN AQUEOUS PHASE AND A LOW MELTING POINT APOLAR WAX | May 2020 | September 2022 | Abandon | 28 | 0 | 1 | No | No |
| 16799042 | MICROALGAE EXTRACT FOR AGRICULTURAL USE | February 2020 | May 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16624854 | COMPOSITION FOR STABILIZING AT LEAST ONE AGROCHEMICAL ACTIVE INGREDIENT | December 2019 | May 2022 | Abandon | 28 | 0 | 1 | No | No |
| 16613345 | SEED, SOIL, AND PLANT TREATMENT COMPOSITIONS | November 2019 | May 2022 | Abandon | 30 | 2 | 1 | No | No |
| 16611798 | Use Of N-Alkyl Glucamides For Reducing Drift During The Application Of Glufosinate-Containing Plant Treatment Agents | November 2019 | May 2022 | Abandon | 30 | 1 | 1 | No | No |
| 16468256 | ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING AN UNMICRONIZED SELECTIVE PROGESTERONE RECEPTOR AS ACTIVE AGENT | June 2019 | April 2022 | Abandon | 34 | 1 | 1 | No | No |
| 16319065 | GRACILARIA BASED COMPOSITIONS FOR PLANTS AND METHODS OF APPLICATION | January 2019 | September 2022 | Abandon | 44 | 0 | 1 | No | No |
| 16313283 | PYRIDINE-BASED COMPOUND INCLUDING ISOXAZOLINE RING AND USE THEREOF AS HERBICIDE | December 2018 | July 2022 | Abandon | 43 | 2 | 1 | No | No |
| 16192337 | UNIT DOSES, AEROSOLS, KITS, AND METHODS FOR TREATING HEART CONDITIONS BY PULMONARY ADMINISTRATION | November 2018 | June 2022 | Abandon | 43 | 4 | 1 | Yes | No |
| 16179623 | LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY | November 2018 | May 2022 | Abandon | 42 | 2 | 1 | No | No |
| 16080758 | NETWORKED DISPERSION OF BIOCELLULOSE MICROFIBRILS IN WATER | August 2018 | September 2022 | Abandon | 49 | 4 | 1 | Yes | No |
| 15949956 | FORMULATION FOR TOPICAL WOUND TREATMENT | April 2018 | May 2019 | Abandon | 14 | 2 | 0 | No | No |
| 15923095 | Sustained Release Cannabinoid Formulations | March 2018 | July 2022 | Abandon | 52 | 2 | 1 | No | No |
| 15834805 | CORE STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF | December 2017 | September 2022 | Abandon | 57 | 7 | 0 | No | No |
| 15577176 | ZINC OXIDE-CONTAINING COMPOSITE PARTICLE, ULTRAVIOLET-SHIELDING COMPOSITION, AND COSMETIC | November 2017 | June 2022 | Abandon | 55 | 4 | 0 | Yes | No |
| 15802405 | COATING-TYPE CONTACT MEDIUM FOR ULTRASOUND DIAGNOSIS | November 2017 | July 2020 | Abandon | 32 | 2 | 0 | Yes | No |
| 15794534 | METHOD FOR STIMULATION OF SEEDS | October 2017 | January 2020 | Allow | 27 | 2 | 0 | Yes | No |
| 15700405 | TRANSDERMAL PREPARATION | September 2017 | March 2019 | Abandon | 18 | 1 | 0 | No | No |
| 15550546 | USE OF A COMBINATION OF TAURINE OR A DERIVATIVE THEREOF, BIOTIN AND GRAPE EXTRACT FOR COMBATING FINE HAIR | August 2017 | June 2022 | Abandon | 58 | 4 | 0 | Yes | No |
| 15672556 | 3D Ti-6Al-4V Structures with Hydrogel Matrix | August 2017 | September 2022 | Abandon | 60 | 5 | 0 | No | No |
| 15548616 | PROCESS FOR GRANULATING SEVELAMER CARBONATE | August 2017 | April 2019 | Abandon | 21 | 2 | 0 | No | No |
| 15535326 | AGENT FOR HYPODERMIC INJECTIONS AND PRODUCTION METHOD FOR SYRINGES CONTAINING AGENT FOR HYPODERMIC INJECTIONS | June 2017 | March 2019 | Abandon | 21 | 2 | 0 | No | No |
| 15486418 | COMPOSITIONS AND KITS FOR COMPOUNDING PHARMACEUTICALS | April 2017 | March 2019 | Abandon | 23 | 1 | 1 | No | No |
| 15475114 | METHOD FOR PREPARING NOBLE METAL NANOPARTICLES FROM MYRRH | March 2017 | May 2021 | Abandon | 49 | 4 | 0 | No | Yes |
| 15429066 | Sun protection towelettes | February 2017 | March 2019 | Abandon | 25 | 1 | 0 | No | No |
| 15328406 | SYSTEM FOR THE IMMEDIATE RELEASE OF ACTIVE AGENTS | January 2017 | June 2022 | Abandon | 60 | 4 | 1 | No | No |
| 15326016 | METHODS AND RELATED COMPOSITIONS FOR IMPROVED DRUG BIOAVAILABILITY AND DISEASE TREATMENT | January 2017 | July 2019 | Abandon | 30 | 2 | 1 | No | No |
| 15336764 | COMBINATION OF NATURAL SUBSTANCES COMPRISING AT LEAST ONE GLYCYRRHETINIC ACID AND AT LEAST ONE GUGGULSTERONE, AND USE THEREOF FOR COSMETIC APPLICATIONS | October 2016 | March 2019 | Abandon | 29 | 1 | 0 | No | No |
| 15300736 | COMPOSITION COMPRISING EXTRACT OF ALPINE WORMWOOD | September 2016 | August 2019 | Abandon | 35 | 2 | 0 | No | No |
| 15236897 | Herbicide And Method Of Applying A Herbicide | August 2016 | February 2021 | Abandon | 54 | 2 | 0 | No | Yes |
| 15138882 | PROCESS FOR PREPARING WATER DISPERSIONS CONTAINING HIGH CONCENTRATION OF NANO/SUBMICRON, HYDROPHOBIC, FUNCTIONAL COMPOUNDS AND WATER DISPERSIONS OBTAINABLE THEREFROM | April 2016 | July 2019 | Abandon | 39 | 3 | 1 | Yes | No |
| 15136379 | COMPOSITION COMPRISING AN ACTIVE INGREDIENT COMPOSITION AND AN ADDITIVE COMPOSITION FOR PENETRATING A TIMBER | April 2016 | August 2020 | Abandon | 52 | 0 | 2 | Yes | No |
| 15065017 | COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION | March 2016 | August 2019 | Abandon | 41 | 3 | 1 | Yes | No |
| 11913160 | Compositions and Methods for Treating Microorganism | November 2015 | September 2016 | Abandon | 60 | 1 | 1 | Yes | No |
| 14848399 | ROSEOBACTICIDES AND USES THEREOF | September 2015 | May 2017 | Abandon | 20 | 1 | 0 | No | No |
| 14837418 | PESTICIDAL COMPOSITIONS | August 2015 | May 2017 | Abandon | 20 | 1 | 0 | No | No |
| 14799895 | COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING RESISTANCE OF INSECTS TO INSECTICIDES | July 2015 | April 2017 | Abandon | 21 | 1 | 0 | No | No |
| 14792826 | METHOD AND SYSTEM FOR EXTRACTING AND USING MOOMIYO COMPOSITIONS | July 2015 | July 2017 | Abandon | 25 | 2 | 1 | Yes | No |
| 14739053 | TOPOGRAPHICAL GEOMETRICAL MATRICES AND USES THEREOF | June 2015 | June 2021 | Abandon | 60 | 7 | 0 | No | Yes |
| 14647837 | USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYLETHYNYL)-BICYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS | May 2015 | May 2017 | Abandon | 23 | 0 | 1 | No | No |
| 14647852 | USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS | May 2015 | May 2017 | Abandon | 23 | 0 | 1 | No | No |
| 14656406 | TRANSDERMAL CANNABINOID PATCH | March 2015 | March 2019 | Abandon | 48 | 4 | 0 | No | No |
| 14639043 | LIGHT PROTECTING COMPOSITION WITH REDUCED TOTAL AMOUNT OF UV FILTER CONTAINING A POLYSILOXANE-BASED UV FILTER | March 2015 | June 2020 | Abandon | 60 | 4 | 1 | No | Yes |
| 14424256 | USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | February 2015 | January 2017 | Abandon | 23 | 1 | 0 | No | No |
| 14424260 | USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | February 2015 | February 2017 | Abandon | 24 | 1 | 0 | No | No |
| 14424284 | USE OF SUBSTITUTED BENZODIAZEPINONES AND BENZAZEPINONES OR THE SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | February 2015 | February 2017 | Abandon | 24 | 1 | 0 | No | No |
| 14587554 | CONJUGATES COMPRISING AN N-OXIME BOND AND ASSOCIATED METHODS | December 2014 | January 2017 | Abandon | 25 | 1 | 0 | No | No |
| 14412176 | COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER | December 2014 | May 2018 | Abandon | 41 | 4 | 0 | Yes | Yes |
| 14576807 | NATURAL OIL METATHESIS COMPOSITIONS | December 2014 | March 2019 | Abandon | 51 | 3 | 0 | No | No |
| 14564726 | Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients | December 2014 | October 2020 | Abandon | 60 | 5 | 0 | No | No |
| 14406275 | CROP ENHANCEMENT | December 2014 | January 2017 | Abandon | 26 | 2 | 0 | No | No |
| 14527812 | HYDROPHILIZATION POLYMERS AND METHODS FOR USE | October 2014 | January 2017 | Abandon | 27 | 1 | 0 | No | No |
| 14395396 | SILK FIBROIN-BASED PERSONAL CARE COMPOSITIONS | October 2014 | May 2022 | Abandon | 60 | 6 | 1 | Yes | Yes |
| 14513306 | POLYURETHANE DISPERSIONS FOR SEALING THE TEATS OF THE MAMMARY GLANDS IN MILKING ANIMALS | October 2014 | March 2019 | Abandon | 53 | 2 | 0 | Yes | Yes |
| 14513994 | NANOPARTICLE PEG MODIFICATION WITH H-PHOSPHONATES | October 2014 | December 2016 | Abandon | 26 | 1 | 1 | No | No |
| 14469846 | COMPOSITIONS FOR IMPROVED TISSUE OXYGENATION BY PERITONEAL VENTILATION | August 2014 | February 2020 | Allow | 60 | 6 | 0 | Yes | No |
| 14452663 | DEODORIZING AND SKIN CLEANING | August 2014 | September 2019 | Abandon | 60 | 9 | 0 | Yes | No |
| 14307438 | Antiperspirant Spray Devices and Compositions | June 2014 | March 2019 | Abandon | 57 | 6 | 0 | No | No |
| 14307433 | Antiperspirant Spray Devices and Compositions | June 2014 | March 2019 | Abandon | 57 | 6 | 0 | No | No |
| 14355905 | Hydrophilic Organosilanes | May 2014 | March 2019 | Abandon | 59 | 6 | 0 | Yes | No |
| 14355246 | OIL-IN-WATER TYPE EMULSIFIED SUNSCREEN COSMETIC | April 2014 | September 2019 | Abandon | 60 | 6 | 0 | No | Yes |
| 14109976 | Antimicrobial Ophthalmic Devices | December 2013 | November 2019 | Abandon | 60 | 3 | 0 | No | Yes |
| 14124604 | INHIBITION OF FATTY ACID AND CHOLESTEROL UPTAKE BY CARBON MONOXIDE (CO) | December 2013 | August 2015 | Allow | 20 | 4 | 0 | No | No |
| 14115276 | Compositions Comprising Siloxane Polymer | November 2013 | March 2019 | Abandon | 60 | 3 | 1 | No | Yes |
| 13992946 | Dosage Form | August 2013 | January 2020 | Abandon | 60 | 6 | 1 | No | Yes |
| 13975606 | DROPPER DEVICE FOR CONTROLLED DISTRIBUTION OF A MAKE-UP PRODUCT | August 2013 | April 2019 | Abandon | 60 | 6 | 1 | Yes | No |
| 13773016 | Modafinil Formulations | February 2013 | April 2014 | Abandon | 14 | 1 | 0 | No | No |
| 13695646 | DELAYED RELEASE ORAL DISINTEGRATING PHARMACEUTICAL COMPOSITIONS OF LANSOPRAZOLE | December 2012 | July 2019 | Abandon | 60 | 8 | 0 | Yes | No |
| 13383067 | Peracid/Peroxide Composition, Process for Accurately Making the Same, and Method for Use as an Evaporating Film Anti-Microbial Solution and as a Photosensitizer | November 2012 | May 2015 | Abandon | 41 | 2 | 1 | No | Yes |
| 13494848 | SYNCHRONIZED WATER AND PRODUCTION AND USE THEREOF | June 2012 | October 2020 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 13510126 | POLYETHYLENE GLYCOL CONTAINING COMPOSITION FOR SHAVING | May 2012 | April 2019 | Abandon | 60 | 6 | 1 | No | Yes |
| 13379486 | ORAL DOSAGE FORMS | March 2012 | July 2020 | Abandon | 60 | 6 | 0 | No | Yes |
| 13401519 | METHOD FOR TREATING AIRWAY HYPER-RESPONSIVENESS WITH LIPOXIN ANALOGS | February 2012 | February 2014 | Abandon | 24 | 1 | 0 | No | No |
| 13312143 | COMPOSITIONS AND METHODS FOR DELIVERY OF SOLUTION TO THE SKIN | December 2011 | February 2014 | Abandon | 27 | 1 | 0 | No | No |
| 13126639 | USE OF HELIUM-OXYGEN GAS MIXTURES FOR TREATING PULMONARY ARTERIAL HYPERTENSION | July 2011 | February 2014 | Abandon | 34 | 0 | 1 | No | No |
| 13125316 | ANTIPERSPIRANT PREPARATIONS COMPRISING HYDROTALCITE | May 2011 | July 2019 | Abandon | 60 | 4 | 1 | Yes | Yes |
| 13099426 | Delivery of estrogen and bioequivalents thereof via the pulmonary tract | May 2011 | April 2014 | Abandon | 36 | 1 | 0 | No | No |
| 13080034 | Clear or Translucent Composition | April 2011 | July 2019 | Abandon | 60 | 12 | 0 | No | No |
| 12933546 | Process Of Making A Stable Aqueous Dispersion Of Concentrated, Finely Divided Particles Of A Biocide | December 2010 | February 2014 | Abandon | 41 | 1 | 1 | No | No |
| 12865607 | TREATMENT OF ADENOCARCINOMA EXPRESSING LKB1 WITH MTOR INHIBITOR IN COMBINATION WITH COX2 INHIBITOR | December 2010 | February 2014 | Abandon | 43 | 4 | 1 | No | No |
| 12895936 | Compositions and Methods for Enhancing Eyelashes | October 2010 | May 2022 | Abandon | 60 | 9 | 0 | No | No |
| 12934286 | FORMULATION WITH REDUCED HYGROSCOPICITY | September 2010 | October 2016 | Abandon | 60 | 3 | 0 | No | Yes |
| 12740116 | USE OF ZERO-ORDER DIFFRACTIVE PIGMENTS | September 2010 | June 2017 | Abandon | 60 | 3 | 1 | Yes | Yes |
| 12920506 | Cosmetic Compositions For Imparting Superhydrophobic Films | September 2010 | April 2019 | Abandon | 60 | 12 | 1 | No | No |
| 11573112 | Controlled-Release Agricultural Chemical Formulation | April 2007 | January 2019 | Abandon | 60 | 11 | 1 | Yes | Yes |
| 11482761 | Photoprotective compositions comprising an aqueous phase and a low melting point apolar wax | July 2006 | November 2023 | Abandon | 60 | 14 | 1 | Yes | Yes |
| 10254707 | SUSTAINED RELEASE RANOLAZINE FORMULATIONS | September 2002 | December 2002 | Allow | 3 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LIU, SUE XU.
With a 5.9% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LIU, SUE XU works in Art Unit 1616 and has examined 94 patent applications in our dataset. With an allowance rate of 4.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner LIU, SUE XU's allowance rate of 4.3% places them in the 0% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LIU, SUE XU receive 3.14 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LIU, SUE XU is 41 months. This places the examiner in the 5% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +5.5% benefit to allowance rate for applications examined by LIU, SUE XU. This interview benefit is in the 31% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 0.6% of applications are subsequently allowed. This success rate is in the 0% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 5.1% of cases where such amendments are filed. This entry rate is in the 2% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 5.6% of appeals filed. This is in the 1% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 88.9% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.